Jun‐ichi Sawada
Papers
1
Total Citations
35
H-Index
1
About
Dr. Jun‑ichi Sawada is a leading figure in pancreatic cancer research, with a particular focus on predictive biomarkers and personalized therapy. His most cited work, “Survival Prediction for Pancreatic Cancer Patients Receiving Gemcitabine Treatment” (2010, 35 citations), addresses a critical clinical challenge: while gemcitabine remains a standard treatment for advanced pancreatic cancer, patient responses vary widely, and many derive minimal benefit. In this study, Sawada employed liquid chromatography‑mass spectrometry (LC‑MS) to identify novel biomarkers that could predict overall survival, pioneering a more tailored approach to chemotherapy. His contributions have advanced the understanding of how molecular profiling can guide treatment decisions, potentially sparing patients from ineffective therapies and improving outcomes. Through his research, Sawada has helped bridge the gap between proteomics and clinical oncology, offering new tools for risk stratification in one of the most aggressive cancers. His work continues to inspire efforts toward precision medicine in pancreatic cancer care.
Research Focus
Key Achievements
Top Papers
- 1